Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects ( Nature volume 653, pages 770–775 (2026))
Journal of Diabetes Investigation · 2026-11 · 17 (11) · 1870-1872
DOI: 10.1111/jdi.70436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 11.09.2026. Verfasst von Gotaro Toda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Metabolic Diseases, The University of Tokyo Hospital, Tokyo, Japan. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Diabetes and Metabolic Diseases, The University of Tokyo Hospital, Tokyo, Japan.
ORCID-Profile: Gotaro Toda, Toshimasa Yamauchi
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Toda, G., & Yamauchi, T. (2026). Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects ( Nature volume 653, pages 770–775 (2026)). Journal of Diabetes Investigation, 17(11), 1870-1872. https://doi.org/10.1111/jdi.70436
Vancouver
Toda G, Yamauchi T. Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects ( Nature volume 653, pages 770–775 (2026)). Journal of Diabetes Investigation. 2026;17(11):1870-1872. doi:10.1111/jdi.70436
BibTeX
@article{Toda2026,
author = {Toda, Gotaro and Yamauchi, Toshimasa},
title = {Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects ( Nature volume 653, pages 770–775 (2026))},
journal = {Journal of Diabetes Investigation},
year = {2026},
volume = {17},
number = {11},
pages = {1870--1872},
doi = {10.1111/jdi.70436}
}
EUVIMED